Impact of CD44 alternative splicing on the response to anticancer drugs. - Marin JJG; Asensio M; Álvarez-Fernández L; Hortelano-Hernandez N; Delgado-Calvo K; Marijuan RP; Perez-Silva L; Benizri LO; Gallai D; Lozano E; Macias RIR; Briz O; et al. (Biochemical pharmacology, 2026)